There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

In addition, HHS Secretary Robert F. Kennedy Jr addressed the delay in Novavax's approval in a CBS interview earlier this ...